Upgrade to SI Premium - Free Trial

TD Cowen Positive on Cellebrite (CLBT): 'Well Positioned As AI Provides Next Growth Layer'

June 4, 2026 3:54 PM
TD Cowen analyst Shaul Eyal reiterated a Buy rating and $23.00 price target on Cellebrite (NASDAQ: CLBT).The analyst comments "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

AI Analyst Comments Hot Comments